Evedientes, Jun Mae .
HRN: 23-53-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2023
10/03/2023
IV DRIP
190mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes